Devens Medical Tech Firm Acquired for $104M


JUNE 19, 2013 | By Matt Pilon

Devens-based Bionostics Inc. has agreed to be acquired for $104 million in cash, according to Minnesota-based Techne Corp.

Bionostics develops, manufactures and sells controls to test the proper operation of in-vitro diagnostic devices primarily used for blood glucose and blood gas testing. The company was founded in 1981 and had $29.3 million in revenue for its last fiscal year, ended Aug. 31, 2012, according to Techne.

Read more via Devens Medical Tech Firm Acquired For $104M | MetroWest495 Biz


Please enter your comment!
Please enter your name here